Ranking Celebrity Cannabis Brands in 2026: Who’s Thriving and Who’s Failing
Celebrity cannabis brands have become one of the most fascinating experiments in modern consumer products. The premise is simple: attach a famous name and face to cannabis flower, edibles, or vapes, and capitalize on the celebrity’s existing audience and cultural cachet to move product. The reality is far more nuanced. Some celebrity brands have evolved into legitimate cannabis companies with quality products, loyal customers, and sustainable business models. Others were transparent cash grabs that degraded both the celebrity’s reputation and the cannabis industry’s credibility.
In 2026, we have enough data — sales figures, shelf longevity, consumer reviews, and market presence — to separate the real operations from the vanity projects. Here is our honest assessment.
The Tier System
We are ranking celebrity cannabis brands across five criteria:
- Product Quality: Is the cannabis actually good? Lab results, terpene profiles, cure quality, and consumer feedback.
- Authenticity: Does the celebrity genuinely engage with cannabis culture, or is this purely transactional?
- Market Presence: How widely distributed is the brand, and is distribution growing or shrinking?
- Business Sustainability: Is the brand profitable or on a path to profitability, or is it burning through licensing fees?
- Industry Impact: Has the brand contributed positively to the cannabis industry beyond just selling product?
Tier 1: The Real Ones
Snoop Dogg — Leafs by Snoop / Death Row Cannabis
No ranking of celebrity cannabis brands can start anywhere else. Snoop Dogg’s relationship with cannabis is not a brand strategy — it is a four-decade cultural identity that predates legal cannabis by decades. His evolution from Leafs by Snoop (launched in 2015 in Colorado) to the Death Row Cannabis rebrand reflects both personal brand evolution and market maturation.
What Works: Snoop’s authenticity is unassailable. The product line spans flower, edibles, and concentrates at multiple price points, making it accessible rather than exclusively premium. Distribution covers most major legal markets. Most importantly, Snoop is actively involved in product selection and brand direction — this is not a licensing deal where the celebrity disappears after the launch press release.
Product Quality: Consistently above average. Not the absolute top shelf in any market, but reliably good flower with proper cure and respectable terpene profiles. The edibles line, particularly the fruit chews, has developed a genuine consumer following.
Rating: A
Mike Tyson — Tyson 2.0
Mike Tyson’s cannabis brand has been one of the most surprising success stories in the space. Launched with skepticism — another retired athlete cashing in — Tyson 2.0 has evolved into a multi-state operation with genuinely innovative products and strong retail performance.
What Works: The brand leans into Tyson’s personality with humor and self-awareness (the ear-shaped edibles are genuinely clever marketing). More importantly, the team behind Tyson 2.0 includes experienced cannabis operators who bring operational credibility. Distribution has expanded aggressively, and the brand maintains strong sell-through rates — a critical metric that indicates consumer demand rather than just shelf placement.
Product Quality: Good to very good. The flower is sourced from reputable cultivators in each market, and the edibles line has earned a strong reputation for consistent dosing and flavor.
Rating: A-
Wiz Khalifa — Khalifa Kush
Khalifa Kush operates differently from most celebrity brands — it is built around a specific cultivar (the Khalifa Kush strain) rather than a broad product portfolio. This focused approach has given the brand a clarity of identity that broader celebrity lines often lack.
What Works: The strain itself has genuine cult status. Wiz Khalifa’s cannabis credibility, while not quite at Snoop’s level, is authentic and longstanding. The brand’s controlled expansion — maintaining quality over rapid distribution growth — has preserved its premium positioning.
Product Quality: Excellent. Khalifa Kush consistently delivers on terpene profile and potency, and the limited-edition drops create genuine consumer excitement.
Rating: A-
Tier 2: Solid Performers
Seth Rogen — Houseplant
Seth Rogen’s Houseplant has become a case study in how to build a celebrity cannabis brand that transcends the celebrity. The brand’s design aesthetic — clean, modern, almost Muji-like — is instantly recognizable and has influenced broader cannabis packaging design. Rogen and co-founder Evan Goldberg are genuinely involved in the business.
What Works: The brand identity is strong enough that many consumers buy Houseplant for the brand experience rather than the celebrity attachment. The houseware line (ashtrays, lighters, storage containers) creates a lifestyle ecosystem that deepens brand loyalty.
Where It Falls Short: Houseplant’s premium pricing limits its market to urban dispensaries in higher-income areas. Distribution remains narrower than the brand’s cultural footprint would suggest. The cannabis itself is good but not consistently great — quality control across multiple state markets has been uneven.
Rating: B+
Jay-Z — Monogram
Jay-Z’s Monogram launched with enormous fanfare and ultra-premium positioning — $50+ eighths in a market where consumers are increasingly price-sensitive. The brand has matured since its 2020 launch, adjusting pricing and expanding its product line.
What Works: The branding and packaging are impeccable. Jay-Z’s involvement with The Parent Company (now restructured) brought real capital and business infrastructure to the brand. The social equity component — directing a percentage of profits to communities impacted by cannabis prohibition — adds substance to the celebrity association.
Where It Falls Short: Monogram has struggled with the fundamental challenge of ultra-premium cannabis: at the highest price points, consumers expect absolute perfection, and no brand delivers that consistently across every batch. Some consumer reviews describe purchasing experiences that did not justify the premium. The brand’s association with The Parent Company’s financial difficulties has also created headwinds.
Rating: B
Bella Thorne — Forbidden Flowers
A surprising entry on this list, Bella Thorne’s Forbidden Flowers has quietly built a respectable brand in select markets. The brand targets a younger, aesthetics-conscious demographic that many cannabis brands overlook.
What Works: The branding is distinctive and appealing to its target audience. Thorne’s social media presence drives genuine consumer awareness. The product line — focused on pre-rolls and vapes — matches the consumption preferences of the target demographic.
Product Quality: Average to above average. Not a destination brand for cannabis connoisseurs, but consistently acceptable product at accessible price points.
Rating: B-
Tier 3: Work in Progress
Gwyneth Paltrow — Goop Cannabis
Gwyneth Paltrow’s entry into cannabis through the Goop brand was perhaps inevitable given Goop’s wellness positioning. The cannabis line focuses on CBD products, low-dose edibles, and wellness-oriented formulations.
What Works: The Goop audience is a perfect match for cannabis wellness products. The brand’s emphasis on education and approachability is genuinely helpful for cannabis-curious consumers who might be intimidated by traditional dispensary culture.
Where It Falls Short: The Goop brand carries baggage — years of pseudoscientific wellness claims make cannabis-skeptical consumers and industry insiders wary. The product line is limited and heavily CBD-focused, which restricts revenue potential. For consumers interested in evidence-based cannabis science, our article on cannabis and ADHD research represents the kind of rigorous analysis that wellness brands often lack.
Rating: C+
David Beckham — DB Cannabis Ventures
David Beckham’s entry into the cannabis space has been cautious and strategic — primarily an investment and licensing play across European markets where his brand recognition is strongest. The actual product line remains limited.
What Works: The Beckham brand carries enormous global recognition. His focus on emerging European markets, rather than competing in the saturated US market, shows strategic awareness.
Where It Falls Short: Product is minimal. The brand feels more like a licensing placeholder than an operational cannabis company. Without meaningful product in market, it is impossible to evaluate quality.
Rating: C
Tier 4: Struggling or Failed
Several brands occupy this tier, and naming them all would require more space than they deserve. The common patterns among failed celebrity cannabis brands:
The Licensing-Only Model: Celebrity lends their name, takes a fee, and has zero involvement in product development or quality control. When the product disappoints, the brand has no internal mechanism for improvement.
The Launch-and-Abandon: Enormous press coverage at launch, followed by declining shelf presence as the celebrity moves on to the next endorsement deal and the operating partner struggles without ongoing celebrity engagement.
The Mismatched Audience: A celebrity whose audience has no overlap with cannabis consumers. The brand generates curiosity purchases but no repeat buyers.
The Quality Gap: Charging premium prices for mid-grade cannabis on the assumption that a famous name alone justifies the markup. Cannabis consumers — particularly experienced ones — are product-quality-focused in ways that most consumer goods categories are not. You cannot sell mediocre flower at top-shelf prices for long, regardless of whose name is on the jar.
What Separates Success from Failure
Analyzing the landscape in 2026, clear patterns emerge about what makes celebrity cannabis brands work:
Authentic Connection to Cannabis Culture
Every successful celebrity brand in Tier 1 is fronted by someone with a genuine, longstanding relationship with cannabis. This is not a coincidence. Cannabis consumers are unusually attuned to authenticity — perhaps because decades of prohibition culture created tight-knit communities with strong norms about who is “real” and who is not.
Operational Competence
The celebrity provides awareness. The operating partner provides quality. Every successful celebrity brand has experienced cannabis operators behind the scenes who understand cultivation, extraction, compliance, and distribution. When the operating partner is weak, no amount of celebrity wattage can compensate.
Pricing Discipline
The most successful celebrity brands price at accessible or moderately premium levels rather than ultra-premium. Cannabis consumers will pay a modest premium for a brand they trust, but the premium ceiling is lower than in most consumer goods categories because the product itself — cannabis flower — is relatively undifferentiated at a molecular level.
Long-Term Commitment
Cannabis brands take years to build. Celebrities who commit to multi-year involvement — attending industry events, engaging with budtenders, providing input on product development — build brands that outlast the initial press cycle. Those who treat cannabis as another endorsement deal are forgotten within a year.
The Future of Celebrity Cannabis
The celebrity cannabis brand wave has crested, and what remains is increasingly legitimate. The easy money has been extracted, the vanity projects have failed, and the surviving brands are operated by people who take the industry seriously.
As cannabis markets continue to mature and consumer preferences calcify around trusted brands, the celebrity brands that survive will be those that function as real cannabis companies first and celebrity vehicles second. The name on the label gets consumers to try the product once. The quality of what is inside the jar determines whether they come back.
The cannabis industry does not need celebrities. But the best celebrity brands — the ones that bring new consumers into legal cannabis, fund social equity programs, and maintain quality standards — are net positive for an industry that still benefits from cultural normalization. The worst ones are already gone from dispensary shelves, which is exactly where market forces should leave them.